187 related articles for article (PubMed ID: 35064767)
1. Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.
Yang X; Cheng Y; Zhou J; Zhang L; Li X; Wang Z; Yin S; Zhai L; Huang T; Wu X; Shen B; Dong Y; Zhao L; Chi Y; Jia Y; Wang J; He Y; Dong X; Xiao H; Wang J
Adv Sci (Weinh); 2022 Mar; 9(8):e2104472. PubMed ID: 35064767
[TBL] [Abstract][Full Text] [Related]
2. A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.
Kawano Y; Sasano T; Arima Y; Kushima S; Tsujita K; Matsuoka M; Hata H
Biochem Biophys Res Commun; 2022 Jan; 587():153-159. PubMed ID: 34875534
[TBL] [Abstract][Full Text] [Related]
3. JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification.
Sun W; Xie Z; Liu Y; Zhao D; Wu Z; Zhang D; Lv H; Tang S; Jin N; Jiang H; Tan M; Ding J; Luo C; Li J; Huang M; Geng M
Cancer Res; 2015 Nov; 75(22):4923-36. PubMed ID: 26483203
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
5. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
[TBL] [Abstract][Full Text] [Related]
7. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
Xu Y; Tong J; Ai Z; Wang J; Teng Y
J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
[TBL] [Abstract][Full Text] [Related]
10. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
11. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
12. High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
Wallbillich JJ; Josyula S; Saini U; Zingarelli RA; Dorayappan KD; Riley MK; Wanner RA; Cohn DE; Selvendiran K
PLoS One; 2017; 12(1):e0170318. PubMed ID: 28114390
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
14. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
15. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of metformin and medroxyprogesterone 17‑acetate on the development of endometrial cancer.
Mu N; Dong M; Li L; Xia M; Qv L; Wang Y; Dong C; Chen Y; Zuo Y; Hou J; Xue F
Oncol Rep; 2018 Apr; 39(4):2015-2021. PubMed ID: 29393479
[TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
[TBL] [Abstract][Full Text] [Related]
18. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming and interventions in endometrial carcinoma.
Li J; Yang H; Zhang L; Zhang S; Dai Y
Biomed Pharmacother; 2023 May; 161():114526. PubMed ID: 36933381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
